Literature DB >> 20966543

Glioblastomas with oligodendroglial component - common origin of the different histological parts and genetic subclassification.

Barbara Klink1, Ben Schlingelhof, Martin Klink, Karen Stout-Weider, Stephan Patt, Evelin Schrock.   

Abstract

BACKGROUND: Glioblastomas are the most common and most malignant brain tumors in adults. A small subgroup of glioblastomas contains areas with histological features of oligodendroglial differentiation (GBMO). Our objective was to genetically characterize the oligodendroglial and the astrocytic parts of GBMOs and correlate morphologic and genetic features with clinical data.
METHODS: The oligodendroglial and the "classic" glioblastoma parts of 13 GBMO were analyzed separately by interphase fluorescence in situ hybridization (FISH) on paraffin sections using a custom probe set (regions 1p, 1q, 7q, 10q, 17p, 19q, cen18, 21q) and by comparative genomic hybridization (CGH) of microdissected paraffin embedded tumor tissue.
RESULTS: We identified four distinct genetic subtypes in 13 GBMOs: an "astrocytic" subtype (9/13) characterized by +7/-10; an "oligodendroglial" subtype with -1p/-19q (1/13); an "intermediate" subtype showing +7/-1p (1/13), and an "other" subtype having none of the former aberrations typical for gliomas (2/13). The different histological tumor parts of GBMO revealed common genetic changes in all tumors and showed additional aberrations specific for each part.
CONCLUSION: Our findings demonstrate the monoclonal origin of GBMO followed by the development of the astrocytic and oligodendroglial components. The diagnostic determination of the genetic signatures may allow for a better prognostication of the patients.

Entities:  

Mesh:

Year:  2010        PMID: 20966543      PMCID: PMC4605661          DOI: 10.3233/ACP-CLO-2010-0530

Source DB:  PubMed          Journal:  Anal Cell Pathol (Amst)        ISSN: 2210-7177            Impact factor:   2.916


  14 in total

1.  1p/19q-driven prognostic molecular classification for high-grade oligodendroglial tumors.

Authors:  Haihui Jiang; Zhe Zhang; Xiaohui Ren; Wei Zeng; Wenqing Jia; Junmei Wang; Song Lin
Journal:  J Neurooncol       Date:  2014-08-24       Impact factor: 4.130

Review 2.  Using the molecular classification of glioblastoma to inform personalized treatment.

Authors:  Adriana Olar; Kenneth D Aldape
Journal:  J Pathol       Date:  2014-01       Impact factor: 7.996

Review 3.  Cancer-initiating enriched cell lines from human glioblastoma: preparing for drug discovery assays.

Authors:  Miriam Romaguera-Ros; María Peris-Celda; Jorge Oliver-De La Cruz; Josefa Carrión-Navarro; Arantxa Pérez-García; Jose Manuel García-Verdugo; Angel Ayuso-Sacido
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

Review 4.  Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies.

Authors:  K Masui; T F Cloughesy; P S Mischel
Journal:  Neuropathol Appl Neurobiol       Date:  2012-06       Impact factor: 8.090

5.  Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma.

Authors:  J A Carrillo; A Lai; P L Nghiemphu; H J Kim; H S Phillips; S Kharbanda; P Moftakhar; S Lalaezari; W Yong; B M Ellingson; T F Cloughesy; W B Pope
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-09       Impact factor: 3.825

6.  Glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcome.

Authors:  Yongzhi Wang; Shouwei Li; Lingchao Chen; Gan You; Zhaoshi Bao; Wei Yan; Zhendong Shi; Yin Chen; Kun Yao; Wei Zhang; Chunsheng Kang; Tao Jiang
Journal:  Neuro Oncol       Date:  2012-02-10       Impact factor: 12.300

Review 7.  Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.

Authors:  Alexandra McAleenan; Hayley E Jones; Ashleigh Kernohan; Tomos Robinson; Lena Schmidt; Sarah Dawson; Claire Kelly; Emmelyn Spencer Leal; Claire L Faulkner; Abigail Palmer; Christopher Wragg; Sarah Jefferies; Sebastian Brandner; Luke Vale; Julian Pt Higgins; Kathreena M Kurian
Journal:  Cochrane Database Syst Rev       Date:  2022-03-02

8.  Moving toward molecular classification of diffuse gliomas in adults.

Authors:  Brett J Theeler; W K Alfred Yung; Gregory N Fuller; John F De Groot
Journal:  Neurology       Date:  2012-10-30       Impact factor: 9.910

9.  Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells.

Authors:  Anna Golebiewska; Sébastien Bougnaud; Daniel Stieber; Nicolaas H C Brons; Laurent Vallar; Frank Hertel; Barbara Klink; Evelin Schröck; Rolf Bjerkvig; Simone P Niclou
Journal:  Brain       Date:  2013-03-04       Impact factor: 13.501

10.  Novel CIC point mutations and an exon-spanning, homozygous deletion identified in oligodendroglial tumors by a comprehensive genomic approach including transcriptome sequencing.

Authors:  Sophie Eisenreich; Khalil Abou-El-Ardat; Karol Szafranski; Jaime A Campos Valenzuela; Andreas Rump; Janice M Nigro; Rolf Bjerkvig; Eva-Maria Gerlach; Karl Hackmann; Evelin Schröck; Dietmar Krex; Lars Kaderali; Gabriele Schackert; Matthias Platzer; Barbara Klink
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.